BridgeMD
New treatment option for Colo-rectal Cancer
Official title The AIDPRO-CRC Trial
ClinicalTrials.gov ID: NCT06645015
What this study is testing
- What it's testing
- The AIDPRO-CRC trial aims to improve outcomes for patients undergoing surgery for colorectal cancer by using artificial intelligence (AI) to assist surgeons in risk assessment. The trial will evaluate whether AI can help surgeons better predict the risk of complications and death, leading to improved care, fewer complications, and better use of healthcare resources.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- patients To be eligible for study participation, the following criteria must be met:
- Histologically confirmed diagnosis or strong clinical suspicion of first-time colon or rectal cancer, clinical stage I-IV.
- Signed written informed consent obtained prior to any study-specific procedures.
- Age ≥18 years at the time of consent.
- Scheduled for potentially curative surgery as determined by a multidisciplinary team (MDT) conference.
You likely can't join if
- patients A patient will be excluded from the study if:
- Surgery with curative intent is no longer planned despite previous eligibility. Healthcare Professionals Surgeons and other healthcare professionals...
- Be licensed medical doctors.
- Be either board-certified specialists in surgical oncology or currently in training to become one. Exclusion criteria - healthcare professionals...
See the full eligibility criteria
- patients To be eligible for study participation, the following criteria must be met:
- Histologically confirmed diagnosis or strong clinical suspicion of first-time colon or rectal cancer, clinical stage I-IV.
- Signed written informed consent obtained prior to any study-specific procedures.
- Age ≥18 years at the time of consent.
- Scheduled for potentially curative surgery as determined by a multidisciplinary team (MDT) conference.
- Availability of all required input variables for the AI model not directly assessed by the surgeon (e.g., ASA score, WHO performance status).
- patients A patient will be excluded from the study if:
- Surgery with curative intent is no longer planned despite previous eligibility. Healthcare Professionals Surgeons and other healthcare professionals involved in the use of the AI-based platform will be invited to...
- Be licensed medical doctors.
- Be either board-certified specialists in surgical oncology or currently in training to become one. Exclusion criteria - healthcare professionals There are no exclusion criteria for participation in the survey or...
The study team makes the final eligibility decision.
Where it's taking place
- Aalborg, Denmark
- Herning, Denmark
- Hillerød, Denmark
- Hvidovre, Denmark
- Randers, Denmark
- Svendborg, Denmark
- Viborg, Denmark
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalborg, Denmark; Herning, Denmark; Hillerød, Denmark; Hvidovre, Denmark; Randers, Denmark; Svendborg, Denmark and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.